NCT03370562View on ClinicalTrials.gov

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

March 20, 2020

Study Completion Date

December 31, 2020

Conditions
ShiveringNausea and Vomiting, Postoperative
Interventions
DRUG

Dexmedetomidine

Administration of 10 mcg intravenous dexmedetomidine

DRUG

Placebo

Administration of normal saline

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT03370562 - Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering | Biotech Hunter | Biotech Hunter